Bank of Nova Scotia’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.11M Sell
9,643
-8,917
-48% -$1.95M ﹤0.01% 665
2025
Q1
$4.16M Sell
18,560
-51,740
-74% -$11.6M 0.01% 493
2024
Q4
$23M Buy
70,300
+61,004
+656% +$20M 0.04% 266
2024
Q3
$2.79M Buy
9,296
+1,695
+22% +$509K 0.01% 582
2024
Q2
$2.5M Sell
7,601
-1,583
-17% -$521K ﹤0.01% 594
2024
Q1
$3.63M Sell
9,184
-10,871
-54% -$4.3M 0.01% 551
2023
Q4
$7.06M Sell
20,055
-11,697
-37% -$4.12M 0.01% 462
2023
Q3
$11.9M Buy
31,752
+25,704
+425% +$9.64M 0.03% 294
2023
Q2
$2.31M Buy
6,048
+930
+18% +$356K 0.01% 501
2023
Q1
$1.77M Sell
5,118
-1,000
-16% -$346K 0.01% 570
2022
Q4
$1.44M Sell
6,118
-32
-0.5% -$7.53K ﹤0.01% 729
2022
Q3
$1.51M Sell
6,150
-8,350
-58% -$2.05M ﹤0.01% 709
2022
Q2
$4.36M Buy
14,500
+4,778
+49% +$1.44M 0.01% 513
2022
Q1
$3.99M Sell
9,722
-28,485
-75% -$11.7M 0.01% 640
2021
Q4
$17.9M Buy
38,207
+5,135
+16% +$2.41M 0.03% 384
2021
Q3
$14M Buy
33,072
+6,724
+26% +$2.85M 0.02% 386
2021
Q2
$9.46M Buy
26,348
+1,151
+5% +$413K 0.02% 436
2021
Q1
$7.1M Sell
25,197
-20,137
-44% -$5.67M 0.01% 482
2020
Q4
$12.8M Buy
45,334
+6,939
+18% +$1.97M 0.03% 325
2020
Q3
$10.6M Sell
38,395
-30,508
-44% -$8.39M 0.03% 331
2020
Q2
$15.7M Buy
68,903
+30,401
+79% +$6.91M 0.05% 239
2020
Q1
$5.86M Buy
+38,502
New +$5.86M 0.02% 393
2019
Q4
Sell
-13,912
Closed -$1.97M 984
2019
Q3
$1.97M Buy
+13,912
New +$1.97M 0.01% 669
2019
Q1
Sell
-43,000
Closed -$4.22M 906
2018
Q4
$4.22M Buy
43,000
+2
+0% +$196 0.02% 427
2018
Q3
$5.31M Buy
+42,998
New +$5.31M 0.02% 412